(Alliance News) - The following is a round-up of updates by London-listed companies, issued this week and not separately reported by Alliance News: Read More
IN BRIEF: PureTech Health operations chief buys GBP50,000 in shares Read More
LONDON BROKER RATINGS: Goldman starts Ceres at Sell, ITM at Neutral Read More
PureTech entity Gelesis starts trading on New York Stock Exchange Read More
IN BRIEF: PureTech Health reveals robust results from LYT-100 test Read More
DIRECTOR DEALINGS: Micro Focus chair and new CFO buy shares Read More
LONDON BROKER RATINGS: Deutsche Bank raises NatWest, cuts Barclays Read More
TRADING UPDATES: Honye Financial loss widens; Highway loss narrows Read More
TRADING UPDATES: FW Thorpe "up and down"; GB Group ties up US merger Read More
IN BRIEF: PureTech Health reaffirms LYT-100 positive trial results Read More
TRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output up Read More
TRADING UPDATES: Sealand's China progress; Altus finds gold Read More
IN BRIEF: PureTech Health's Vedanta posts positive VE303 trial results Read More
TRADING UPDATES: Inland gets Basildon permission; ICG assets grow Read More
TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss Read More
PureTech's Vor Biopharma granted FDA fast track for blood cancer drug Read More
PureTech Health hopes cash will carry it to 2025 amid first half loss Read More
IN BRIEF: PureTech Health's LYT-100 performs well in Phase 1 Read More
UK earnings, trading statements calendar - next 7 days Read More
TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green Read More
